SAM
GILD icon

Satovsky Asset Management’s Gilead Sciences GILD Stock Holding History

Satovsky Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
3,260
+21
+0.6% +$2.77K 0.07% 44
2026
Q1 		$451K Buy
3,239
+19
+0.6% +$2.66K 0.08% 37
2025
Q4 		$395K Buy
3,220
+21
+0.7% +$2.55K 0.08% 37
2025
Q3 		$355K Buy
3,199
+22
+0.7% +$2.5K 0.07% 39
2025
Q2 		$352K Buy
3,177
+24
+0.8% +$2.55K 0.08% 33
2025
Q1 		$353K Buy
3,153
+22
+0.7% +$2.27K 0.08% 34
2024
Q4 		$289K Buy
3,131
+25
+0.8% +$2.25K 0.07% 34
2024
Q3 		$260K Buy
3,106
+29
+0.9% +$2.21K 0.06% 42
2024
Q2 		$211K Buy
3,077
+34
+1% +$2.27K 0.05% 47
2024
Q1 		$223K Buy
3,043
+32
+1% +$2.46K 0.07% 44
2023
Q4 		$244K Buy
3,011
+28
+0.9% +$2.18K 0.08% 40
2023
Q3 		$224K Buy
2,983
+29
+1% +$2.23K 0.08% 37
2023
Q2 		$228K Buy
2,954
+29
+1% +$2.31K 0.08% 38
2023
Q1 		$243K Buy
2,925
+27
+0.9% +$2.24K 0.09% 34
2022
Q4 		$249K Buy
+2,898
New +$229K 0.1% 34
2022
Q1 		– Sell
-2,774
Closed -$201K – 41
2021
Q4 		$201K Buy
+2,774
New +$191K 0.13% 32

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Satovsky Asset Management's GILD Position: Q2 2026 in Review

Satovsky Asset Management increased its Gilead Sciences (GILD) stake by 0.65% in Q2 2026, buying an estimated $2.77K and bringing the position to 3,260 shares worth $412K. The position accounts for 0.07% of the portfolio, ranked #44.

Satovsky Asset Management first reported a position in GILD in Q4 2021 and has held it in 16 quarters since. The position peaked at $451K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Satovsky Asset Management held 3,260 shares of Gilead Sciences worth $412K as of Q2 2026.
  • Satovsky Asset Management bought 21 Gilead Sciences shares in Q2 2026, an estimated $2.77K.
  • Gilead Sciences made up 0.07% of Satovsky Asset Management's portfolio in Q2 2026, its #44 holding.
  • Satovsky Asset Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 16 quarters since.
  • Satovsky Asset Management's Gilead Sciences position peaked at $451K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Satovsky Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.